OOIR: Observatory of International Research

Papers

(The TQCC of Cellular & Molecular Biology Letters is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Molecular interactions of miR-338 during tumor progression and metastasis	168
Protective effects of dexmedetomidine in vital organ injury: crucial roles of autophagy	119
Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review	108
Circulating small extracellular vesicle-encapsulated SEMA5A-IT1 attenuates myocardial ischemia–reperfusion injury after cardiac surgery with cardiopulmonary bypass	99
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development	95
LncRNA DNM3OS regulates GREM2 via miR-127-5p to suppress early chondrogenic differentiation of rat mesenchymal stem cells under hypoxic conditions	94
Targeting microRNAs with thymoquinone: a new approach for cancer therapy	92
MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30	85
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review	84
RETRACTED ARTICLE:Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway	83
Direct differentiation of tonsillar biopsy-derived stem cells to the neuronal lineage	74
Diversification of PAR signaling through receptor crosstalk	72
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway	71
Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease	71
The role of macrophage subtypes and exosomes in immunomodulation	64
ALKBH5 in mouse testicular Sertoli cells regulates Cdh2 mRNA translation to maintain blood–testis barrier integrity	59
Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease	55
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery	52
LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability	51
Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis	49
The role of epigenetic modifications in drug resistance and treatment of breast cancer	48
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC	48
The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability	45
The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer	44
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment	44

MicroRNA let-7 and viral infections: focus on mechanisms of action	44
RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop	43
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects	43
Comprehensive RNA sequencing in primary murine keratinocytes and fibroblasts identifies novel biomarkers and provides potential therapeutic targets for skin-related diseases	40
Laboratory methods to decipher epigenetic signatures: a comparative review	40
mTOR controls endoplasmic reticulum–Golgi apparatus trafficking of VSVg in specific cell types	40
ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1	38
Correction to: ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation	38
Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling	37
Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma	35
DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis	35
CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review	32
SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells	31
ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation	31
Exploring neuronal mechanisms involved in the scratching behavior of a mouse model of allergic contact dermatitis by transcriptomics	31